There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are published in Cell Host & Microbe.
The senior author said that previous therapeutics typically were of the "one bug, one drug" variety. But because of the unpredictable nature and variety of the Ebola virus, scientists have been seeking a way to protect against different strains of the virus.
"Our experimental drug can protect against all forms of Ebola known to harm people, suggesting that it will continue to protect people if the Ebola viruses evolve over time," said the senior author.
The team of scientists demonstrated that a two-antibody cocktail called MBP134 could fully protect nonhuman primates and ferrets against lethal Ebola virus infections of caused by the Bundibugyo and Sudan strain as well as the deadliest Zaire strain that caused the 2013-16 epidemic in West Africa and the current outbreak in the Democratic Republic of Congo.
"We were able to protect the nonhuman primates against all the Ebola species plaguing people at a single low dose," said the president of Mapp Biopharmaceutical Inc. "Further studies exploring even lower doses could open the door to treatment via auto-injectors like the kind used for allergic reactions. The ability to quickly and efficiently provide protection against all Ebola viruses in a single dose would reduce the burden on health care workers in the field during outbreaks, especially in regions that have a less-developed infrastructure."
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(18)30631-0
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(18)30632-2
A single vaccine to treat different strains of Ebola virus
- 526 views
- Added
Edited
Latest News
Sex differences in immune responses!
Neurons regulating early alcohol consumption identified!
A single higher dose of Zika vaccine protects both mom and fetus
Many psychiatric disorders arise from common genes
Mitochondrial DNA stress signalling protects the nuclear genome
Other Top Stories
Structural changes of the adolescent brain in bullying
Cues that drive aggression by males
Astrocytes block neuronal migration after stroke
Contaminated pituitary growth hormone transmitted amyloid-β protein pathology in humans
Disrupting protein-protein interactions to stop Ebola, Dengue, and Zika infections
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes
Maternal vaccination and protective immunity against Zika virus vertical transmission
Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chr…
IgGs from patients with amyotrophic lateral sclerosis and diabetes target CaVα2δ1 subunits impair…
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues
Presentations
Hypoxia Inducible Factor - 1 (HIF-1)
Intracellular Protein Degradation
Pathophysiology of Type 1 Diabetes
Plant Viruses
Regulation by changes in chromatin structure
Posters
AACC-2018-Infectious Disease
AACC-2018-Mass Spectrometry Applications
AACC-2018-Lipids/Lipoproteins
AACC-2018-Management
AACC-2018-Immunology-abstracts